Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The future: critical knowledge about anti-itch therapy.

Claudio Guarneri1, Margherita Terranova, Giuseppe Terranova

  • 1Department of Dermatological Sciences, University of Messina, Italy. claudioguarneri@tiscali.it

Dermatologic Therapy
|November 22, 2005
PubMed
Summary

Current anti-itch treatments often fail because they overlook the complex causes of itching. A new approach integrating skin, nervous, endocrine, and immune systems offers better therapeutic strategies for itch relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Dermatology and therapy·2026
Same author

Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.

Dermatology and therapy·2026
Same author

Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: A target trial emulation using the Italian VALORE distributed database network.

Pharmacological research·2026
Same author

CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients' Lives.

Dermatology practical & conceptual·2026
Same author

Sensitive skin in patients with inflammatory chronic cutaneous disorders: results from an observational study on psoriasis, atopic dermatitis and hand eczema.

Italian journal of dermatology and venereology·2026
Same author

Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Dermatology and therapy·2026

Area of Science:

  • Dermatology
  • Neuroscience
  • Immunology
  • Endocrinology

Background:

  • Itch is a common and debilitating symptom across numerous diseases.
  • Existing anti-itch therapies, primarily based on an "immunocentric" perspective, frequently prove inadequate.
  • Emerging research indicates itch results from intricate interactions between the skin, nervous, endocrine, and immune systems.

Purpose of the Study:

  • To re-evaluate the pathogenesis of itch.
  • To explore novel therapeutic strategies for managing itch.
  • To highlight the limitations of current single-factor treatment approaches.

Main Methods:

  • Review of recent pathogenetic and pharmacologic research on itch.
  • Analysis of the interplay between multiple physiological systems in itch.

Related Experiment Videos

  • Discussion of a multidisciplinary approach to symptomatic treatment.

    • Main Results:

    • The "immunocentric" view is insufficient for understanding itch.
    • Itch involves complex interactions among the skin, nervous, endocrine, and immune systems.
    • A polypharmacologic, individualized, and multidisciplinary treatment strategy is suggested.

    Conclusions:

    • Current anti-itch therapies are often unsatisfactory due to a narrow focus.
    • A comprehensive understanding of itch pathogenesis is crucial for effective treatment.
    • Future anti-itch therapy should adopt a holistic, case-by-case, multidisciplinary approach.